These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 7041597

  • 21. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
    Marks LS, Maxwell MH, Kaufman JJ.
    Ann Intern Med; 1977 Aug; 87(2):176-82. PubMed ID: 889198
    [Abstract] [Full Text] [Related]

  • 22. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS, Maxwell MH, Kaufman JJ.
    Lancet; 1975 Oct 25; 2(7939):784-7. PubMed ID: 78152
    [Abstract] [Full Text] [Related]

  • 23. Captopril in treatment-resistant essential and renal hypertension.
    Aurell M, Delin K, Herlitz H.
    Scand J Urol Nephrol; 1982 Oct 25; 16(3):243-9. PubMed ID: 6761860
    [Abstract] [Full Text] [Related]

  • 24. Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
    Wenting GJ, de Bruyn JH, Man in't Veld AJ, Woittiez AJ, Derkx FH, Schalekamp MA.
    Am J Cardiol; 1982 Apr 21; 49(6):1453-9. PubMed ID: 6803562
    [No Abstract] [Full Text] [Related]

  • 25. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK.
    Am J Med; 1984 May 31; 76(5B):22-8. PubMed ID: 6328983
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The antihypertensive effect of captopril. Evidence for an influence of kinins.
    Mimran A, Targhetta R, Laroche B.
    Hypertension; 1980 May 31; 2(6):732-7. PubMed ID: 6161895
    [Abstract] [Full Text] [Related]

  • 28. Antihypertensive effect of the oral angiotensin I-converting enzyme inhibitor in long-term treatment of hypertensive patients.
    Mizuno K, Gotoh M, Matsui J, Fukuchi S.
    Jpn Heart J; 1981 Nov 31; 22(6):903-13. PubMed ID: 7040724
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP, Karlberg BE, Nilsson OR, Wettre S.
    Acta Med Scand Suppl; 1981 Nov 31; 646():98-105. PubMed ID: 7018190
    [Abstract] [Full Text] [Related]

  • 34. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat.
    DeForrest JM, Knappenberger RC, Antonaccio MJ, Ferrone RA, Creekmore JS.
    Am J Cardiol; 1982 Apr 21; 49(6):1515-7. PubMed ID: 6280481
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Does the renin-angiotensin system maintain blood pressure in both hypertensive and normotensive subjects? A comparison of propranolol, saralasin and captopril.
    MacGregor GA, Markandu ND, Roulston JE.
    Clin Sci (Lond); 1979 Dec 21; 57 Suppl 5():145s-148s. PubMed ID: 396068
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Increase in plasma aldosterone during prolonged captopril treatment.
    Lijnen P, Staessen J, Fagard R, Amery A.
    Am J Cardiol; 1982 Apr 21; 49(6):1561-3. PubMed ID: 7041598
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.